News
Novo Nordisk's Q1 2025 results show a 19% sales increase, 20% operating income growth, and 14% net profit rise. Read why NVO ...
How Does Semaglutide Work for Weight Loss? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Ozempic. Wegovy. Rybelsus. What do these medications have in common? They all contain ...
The pharma giant already has one GLP-1 available in pill form under the name Rybelsus. The FDA cleared that drug in 2019 for blood sugar control in adults with diabetes. Anna Windle is Novo ...
And while it's only a matter of time until Ozempic-like drugs are available ... Novo Nordisk already has an oral semaglutide drug, Rybelsus, on the market but it's only approved for diabetes ...
Novo Nordisk's Ozempic has been shown ... people with T2D and CKD. …as Rybelsus cuts MACE in type 2 diabetics Meanwhile, semaglutide has become the first drug in the GLP-1 class to show that ...
Nevertheless, Novo Nordisk’s diabetes drugs Ozempic and Rybelsus and obesity drug Wegovy are performing well, fueled by increasing demand. Label expansions in cardiovascular and other ...
Lilly's Zepbound overtook Novo's Wegovy as the leading obesity drug, according to the latest ... Novo reported Wegovy and Ozempic combined sales of more than $7.5 billion. Overtaken?
At the top of that list, unsurprisingly, are Novo Nordisk obesity drugs Ozempic, Rybelsus, and Wegovy, all grouped together as a single drug. Eli Lily's GLP-1 competitor Mounjaro/Zepbound doesn't ...
Website landing pages that contain a single call to action (CTA) garner a higher average conversion rate than those with more than one CTA, according to recent research from Unbounce. The report was ...
Data across obesity, cardiovascular disease, MASH, type 2 diabetes, as well as advances in obesity-related care to be presented at ECO 2025 - covering burden, and the value of treatment and prevention ...
The researchers found that, on average, 57% of B2B webinar registrations convert to attendees; the conversion rate of content hubs is 30%; and the conversion rate of personalized landing pages is 25%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results